- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Pembrolizumab – March 2016
Pembrolizumab: 50mg injection: powder for, 1 vial, Keytruda®
Last updated
15 July 2016